Manufacturing

Jennifer Markarian is a contributing editor for 

Articles

Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.

Tracking Technologies Guard Vaccine Cold Chain

Beth Totin is chief commercial officer, ApiJect Systems, Corp.

Marcus Webb is director of communications, ApiJect Systems, Corp.

Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. 

Reducing Packaging Costs for Prefilled Syringes

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Complex formulations, personalized medicines, COVID-19 therapies, and sustainability goals are driving innovations in drug packaging.

Injecting Innovation into Drug Packaging

CalAmp's new sensor for cold-chain applications provides visibility for shipping vaccines.

CalAmp Launches End-To-End Supply Chain Visibility Solution for Cold Chain

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Material properties play a role in container closure integrity under frozen or cryogenic storage temperatures.

Evaluating Cold-Temperature Packaging Closure Systems

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Drug product security requires anti-counterfeiting techniques such as authentication throughout the supply chain.

Package Authentication Depends on Multi-Level Tactics

Dosage-level authentication provides an added digital layer of security for pharmaceutical companies to ensure their products are not exposed to falsification.

Securing Each Dose: Reducing Falsification Risk with Dosage Level Authentication

The partnership will combine Cold Chain Technologies thermal packaging with B Medical Systems’ stationary refrigeration solutions for temperature-critical pharmaceuticals.

Cold Chain Technologies Partners with B Medical Systems 

Under an expanded agreement with J&J, Catalent Biologics will increase manufacturing capacity at its Anagni, Italy, site to accommodate the large-scale commercial supply of Janssen’s COVID-19 vaccine. 

Catalent to Increase Manufacturing Capacity at Italian Facility for J&J COVID-19 Vaccine 

Hallie Forcinio is BioPharm International's packaging editor, editorhal@sbcglobal.net

Smart packaging opens doors to new products for diagnosis and treatment of eye problems. 

Packaging and Distribution